Story perspectives

FDA Commissioner Makary Faces Internal Turmoil Amid Changes

11/17/2025

35 6

Summary

Story summary

On November 15, 2025, reports indicate Food and Drug Administration (FDA) Commissioner Dr. Marty Makary faces challenges amid internal conflicts.
Health Secretary Robert F. Kennedy Jr. considered reducing Makary's responsibilities due to management issues after resignation of drugs director George Tidmarsh.
Officials decided against immediate changes, giving Makary time to improve.
Tensions within FDA hindered communication, as staff struggle to connect with Makary amid changes under U.S. President Donald Trump.

1 of 1

Story summary

On November 15, 2025, reports indicate Food and Drug Administration (FDA) Commissioner Dr. Marty Makary faces challenges amid internal conflicts.
Health Secretary Robert F. Kennedy Jr. considered reducing Makary's responsibilities due to management issues after resignation of drugs director George Tidmarsh.
Officials decided against immediate changes, giving Makary time to improve.
Tensions within FDA hindered communication, as staff struggle to connect with Makary amid changes under U.S. President Donald Trump.